Effect of supplementation in treatment of Coronary Heart Disease

Phase 2

• Conditions: Coronary Heart Disease.; Chronic ischaemic heart disease, unspecified; I25.9

• Registration Number: IRCT2017051333941N1
• Lead Sponsor: Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 December 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Inclusion Criteria: Subjects aged 50-85 years; diagnosed with type 2 diabetes, CHD and overweight.

Exclusion Criteria

Consuming melatonin supplements within the last 3 months
Having an acute myocardial infarction and cardiac surgery within the past 3 months
The night shift workers

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Malondialdehyde. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Spectrophotometry.;Glutathione. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Spectrophotometry.;Total antioxidant capacity. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Spectrophotometry.;Protein carbonyl. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Spectrophotometry.